Oxaprozin
- Generic Name
- Oxaprozin
- Brand Names
- Coxanto, Daypro
- Drug Type
- Small Molecule
- Chemical Formula
- C18H15NO3
- CAS Number
- 21256-18-8
- Unique Ingredient Identifier
- MHJ80W9LRB
Overview
Oxaprozin is a non-narcotic, non-steroidal anti-inflammatory drug (NSAID), used to relieve the inflammation, swelling, stiffness, and joint pain associated with osteoarthritis and rheumatoid arthritis.
Background
Oxaprozin is a non-narcotic, non-steroidal anti-inflammatory drug (NSAID), used to relieve the inflammation, swelling, stiffness, and joint pain associated with osteoarthritis and rheumatoid arthritis.
Indication
Used to relieve the inflammation, swelling, stiffness, and joint pain associated with rheumatoid arthritis and osteoarthritis.
Associated Conditions
- Osteoarthritis (OA)
- Rheumatoid Arthritis
- Rheumatoid Arthritis, Juvenile
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
|---|---|---|---|---|---|
2017/11/22 | Phase 1 | Completed | Mochida Pharmaceutical Company, Ltd. |
FDA Approved Products
Product Name | Manufacturer | Route | Strength | Approved | NDC Code |
|---|---|---|---|---|---|
ORAL | 600 mg in 1 1 | 2013/07/03 | 66336-722 | ||
ORAL | 600 mg in 1 1 | 2019/08/22 | 60760-092 | ||
ORAL | 600 mg in 1 1 | 2017/11/03 | 70332-310 | ||
ORAL | 600 mg in 1 1 | 2023/05/23 | 71335-0902 | ||
ORAL | 600 mg in 1 1 | 2021/07/05 | 71335-0617 | ||
ORAL | 600 mg in 1 1 | 2011/10/14 | 52959-800 | ||
Pfizer Laboratories Div Pfizer Inc | ORAL | 600 mg in 1 1 | 2022/11/17 | 0025-1381 | |
ORAL | 600 mg in 1 1 | 2019/04/19 | 61919-673 | ||
ORAL | 600 mg in 1 1 | 2019/04/19 | 61919-178 | ||
ORAL | 600 mg in 1 1 | 2010/09/08 | 21695-100 |
EMA Approved Products
Medicine Name | EMA Number | Auth. Holder | Country | Drug Type | Status | Issued | Opinion | Revision |
|---|
No EMA products found
No EMA products found for this drug
HSA Approved Products
Product Name | Manufacturer | Dosage Form | Strength | Approved | Approval No. |
|---|
No HSA products found
No HSA products found for this drug
NMPA Approved Products
Product Name | Approval No. | Manufacturer | Dosage Form | Trade Name | Strength | Type | Status | Date | Import |
|---|---|---|---|---|---|---|---|---|---|
国药准字H20010351 | 胶囊剂(肠溶) | N/A | 0.2g | Chemical Drug | Approved | 2020/07/30 | Domestic | ||
国药准字H19991133 | 胶囊剂 | 诺碧松 | 0.2g | Chemical Drug | Approved | 2020/05/19 | Domestic | ||
国药准字H22026597 | 片剂 | 诺德伦 | 0.2g | Chemical Drug | Approved | 2020/06/12 | Domestic | ||
国药准字H10950306 | 片剂(素片) | N/A | 0.2g | Chemical Drug | Approved | 2020/07/28 | Domestic | ||
国药准字H10970256 | 片剂 | 诺松 | 0.2g | Chemical Drug | Approved | 2020/05/19 | Domestic | ||
国药准字H20066784 | 片剂 | N/A | 200mg | Chemical Drug | Approved | 2021/02/19 | Domestic | ||
国药准字H20058705 | 片剂 | N/A | 0.2g | Chemical Drug | Approved | 2020/06/10 | Domestic | ||
国药准字H20000571 | 片剂 | 奥克清 | 0.2g | Chemical Drug | Approved | 2020/06/17 | Domestic | ||
国药准字H20073864 | 片剂 | N/A | N/A | Chemical Drug | Approved | 2017/09/08 | Domestic | ||
国药准字H20031175 | 分散片剂 | 澳谱欣 | 0.2g | Chemical Drug | Approved | 2020/09/02 | Domestic |
PPB Approved Products
Product Name | Registration Code | Company | Category | Sale Type | Reg. Date |
|---|
No PPB products found
No PPB products found for this drug
TGA Approved Products
Product Name | ARTG ID | Sponsor | Status | Reg. Date | Ingredient |
|---|
No TGA products found
No TGA products found for this drug
© Copyright 2025. All Rights Reserved by MedPath